Search the Newsreel

Insider Selling: Customers Bancorp (NYSE:CUBI) Chairman Sells $5,511,873.89 in Stock

Somerset Minerals (ASX:SMM) Jumps as Coppermine Assays Extend the High-Grade Copper Story

Atomera (NASDAQ: ATOM) posts Q2 2026 loss on $158k revenue

Customers Bancorp (NYSE: CUBB) chair sells 68,821 common shares

Customers Bancorp Chairman Jay S. Sidhu sold 68,821 common shares on August 3, 2026, at a weighted average price of $80.0888 per share, totaling approximately $5.51 million. Following this transaction, Sidhu directly holds 667,757 shares, which include 53,669 Restricted Stock Units, and also has …

Omeros (NASDAQ:OMER) Shares Pass Above Two Hundred Day Moving Average - Here's What Happened

Omeros (NASDAQ:OMER) shares recently surpassed their two-hundred-day moving average, closing at $12.94 after reaching $13.05. The biopharmaceutical company reported better-than-expected quarterly earnings, with a loss of $0.24 per share against a projected $0.40 loss, and revenue of $9.89 million against a $4.19 million estimate. …

Atomera Inc (ATOM) (Q2 2026) Earnings Call Highlights: GAA Milestone, New NAND TAM, and GaN ...

Atomera Inc (ATOM) reported its Q2 2026 earnings, highlighting a significant Gate-All-Around (GAA) milestone, expanding its Total Addressable Market (TAM) with a new NAND flash opportunity, and achieving a technical breakthrough in GaN-on-silicon for RF devices. Despite these advancements, the company recorded a wider …

Grupo Comercial Chedraui (BMV:CHDRAUI B) Stock Gets Fair Value Trim After Analyst Caution

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Grupo Comercial Chedraui is in focus after analysts trimmed price targets from MX$125 to MX$120 and then to MX$105 in recent research. These …

Atomera | 8-K: Atomera Provides Second Quarter 2026 Results

Atomera (ATOM) has released its Form 8-K filing, detailing the company's financial results for the second quarter of 2026. This announcement provides investors with key financial performance indicators and operational updates for the recent period. The full document is available for review, offering comprehensive …

Atomera (NASDAQ:ATOM) Issues Quarterly Earnings Results, Misses Estimates By $0.04 EPS

Atomera (NASDAQ:ATOM) reported a Q2 EPS loss of $0.17, missing analyst estimates by $0.04, with revenues of $158,000 and a GAAP net loss of $6.3 million. Despite reaching a significant manufacturability milestone with a Gate-All-Around customer and promising results in DRAM, NAND, and RF …

Earnings call transcript: Atomera posts Q2 2026 revenue beat, shares fall after hours

Atomera (ATOM) reported Q2 2026 revenue of $158,000, exceeding Wall Street estimates, but posted a wider-than-expected loss of $0.17 per share. Despite the revenue beat, shares fell in after-hours trading as investors focused on the earnings miss and higher operating expenses. The company highlighted …

Atomera posts Q2 2026 net loss of $6.3M, revenue $0.16M; cash $38.4M

Atomera reported a Q2 2026 net loss of $6.3 million on revenue of $158,000, with an adjusted EBITDA loss of $5.0 million. The company held $38.4 million in cash and short-term investments as of June 30, 2026. Atomera highlighted progress in GaN-on-silicon for RF …

Atomera Incorporated (NASDAQ: ATOM) posts Q2 2026 results with wider loss, higher cash

Atomera Incorporated reported its Q2 2026 financial results, showing a wider net loss of $6.3 million and an adjusted EBITDA loss of $5.0 million, compared to the previous year. Despite the increased loss, the company significantly grew its cash, cash equivalents, and short-term investments …

Following Strong Earnings, Is Customers Bancorp (CUBI) Still Below Fair Value?

Synthomer (LON:SYNT) Releases Quarterly Earnings Results

Synthomer H1 Earnings Call Highlights

Key Points Interested in Synthomer plc? Here are five stocks we like better. Synthomer delivered a stronger-than-expected first half, with revenue up 6.7%, EBITDA up 13% and margins expanding to 10.1%. Growth was driven by specialty products, cost actions and supply-chain disruption benefits. The …

OMER Stock News Today | Earnings, Events & Price Alerts

Atomera Reports Q2 2026 Net Loss of $6.3 Million

Atomera (ATOM) reported a net loss of $6.3 million, or $0.17 per share, for Q2 2026, on revenue of $158,000. This compares to a net loss of $5.0 million with no revenue in Q2 2025. The company highlighted progress in GaN-on-Silicon and GAA customers, …

Synthomer (LON:SYNT) Earns "Buy" Rating from Peel Hunt

Atomera (ATOM) Earnings Date and Reports 2026 $ATOM

Atomera earnings missed by $0.04, revenue topped estimates

Earnings Flash (SYNT.L) Synthomer plc Posts H1 Loss GBX-3.1

Form 144 ATOMERA INCORPORATED For: 3 August By Investing.com

This article announces a Form 144 filing for Atomera Incorporated, dated August 3rd. It provides standard disclaimers about the risks associated with trading financial instruments and cryptocurrencies. The content emphasizes that data provided by Investing.com is not always real-time or accurate and that Fusion …

Atomera Q2 2026 Earnings Preview

* Atomera (ATOM [https://seekingalpha.com/symbol/ATOM]) is scheduled to announce Q2 earnings results on Tuesday. * The consensus EPS Estimate is -$0.13 [https://seekingalpha.com/symbol/ATOM/earnings/estimates] and the consensus Revenue Estimate is $0.1M * Over the last 1 year, ATOM has beaten EPS estimates [https://seekingalpha.com/symbol/ATOM/earnings/eps-surprise-summary] 25% of the time …

Robert Mears (ATOM) files Form 144 outlining planned and recent stock sales

Robert Mears has filed a Form 144 indicating his intent to sell 1,000 shares of ATOM common stock on August 3, 2026, through Morgan Stanley Smith Barney LLC. The filing also details several past sales of ATOM shares by Mears in June and July …

Is the Options Market Predicting a Spike in Customers Bancorp Stock?

Investors in Customers Bancorp, Inc. CUBI need to pay close attention to the stock based on moves in the options market lately. That is because the Aug. 21, 2026 $40 Put had some of the highest implied volatility of all equity options today. What …

Medicare Hospitals Can Get Up to $287,079 to Treat a Transplant Complication

Omeros Corporation announced that the Centers for Medicare & Medicaid Services (CMS) has granted New Technology Add-On Payment (NTAP) status for its drug YARTEMLEA®. This status allows eligible hospitals to receive up to $287,079 in additional Medicare reimbursement per patient for treating hematopoietic stem …

OMER Stock Gains 4% — CMS Green-Lights $287K Add-On Payments For Transplant Drug

Omeros Corporation (OMER) shares rose 4% after the U.S. Medicare officials approved additional payments of up to $287,000 for hospitals using its drug YARTEMLEA. This drug treats a rare and life-threatening complication of stem cell transplants, and the extra funds aim to help hospitals …

CMS Grants New Technology Add-On Payment (NTAP) Status to YARTEMLEA®

Omeros Corporation announced that the Centers for Medicare & Medicaid Services (CMS) has granted New Technology Add-On Payment (NTAP) status for YARTEMLEA® (narsoplimab-wuug), effective October 1, 2026. This status provides additional Medicare reimbursement to hospitals for treating eligible Medicare patients with hematopoietic stem cell …

Healthcare of Ontario Pension Plan Trust Fund Sells 46,611 Shares of Customers Bancorp, Inc $CUBI

Empresa Distribuidora Y Comercializadora Norte S.A. (Edenor) (EDN) to Release Quarterly Earnings on Monday

Somerset Minerals Uncovers Widespread High-Grade Copper at Canadian Coppermine Project

Omeros Corporation Revenue Breakdown – BX:3O8

This article provides a brief overview of Omeros Corporation (BX:3O8) financials, specifically focusing on its revenue breakdown. It indicates that further details on segments and regional performance can be found on TradingView, which sources data from ICE Data Services, FactSet, and Quartr.

Renaissance Technologies LLC Purchases 45,800 Shares of Customers Bancorp, Inc $CUBI

5 Revealing Analyst Questions From Customers Bancorp’s Q2 Earnings Call

5 Revealing Analyst Questions From Customers Bancorp's Q2 Earnings Call Customers Bancorp's second quarter saw resilient year-on-year revenue growth, though results came in below Wall Street's expectations. Management credited the quarter's performance to a combination of robust deposit gathering, loan growth across diversified commercial …

Empresa Distribuidora Y Comercializadora Norte S.A. (Edenor) (NYSE:EDN) Stock Crosses Above 200 Day Moving Average - Here's What Happened

Atomera (NASDAQ:ATOM) Rating Lowered to Sell at Wall Street Zen

Wall Street Zen has downgraded Atomera (NASDAQ:ATOM) from "hold" to "sell", while Weiss Ratings reaffirmed its "sell (e+)" rating, leading to a consensus "sell" rating from MarketBeat. The company reported a quarterly loss of $0.17 per share and revenue of $0.01 million, both missing …